Intellectual property case studies - Croatia

Pharmaceutics

Pliva

"Azythromocin, a World Best-Selling Antibiotic": patent protection may be the key to commercial success for lacking capital medium-sized company. licensing agreement where both companies, as well as the general public, could benefit from the commercialization of a powerful antibiotic with one of the largest drugmakers in America with sales representatives worldwide, Pfizer
 Pliva maintains the right to sell the product in Central and Eastern Europe under its own brand name and earns royalties on Pfizer's sales. For Pliva, a pharmaceutical company of small proportions in comparison to its licensee Pfizer, the licensing agreement meant a huge breakthrough in terms of annual revenues and allowed it to expand its research activities.

http://www.wipo.int/sme/en/case_studies/pliva.htm